Serum Carotenoids and Risk of Gastrointestinal Tract Cancer: Meta-analysis of Ten Studies

Yong Zhou40,641 enrolled

Overview

Previous studies have suggested that serum carotenoids may be associated with risk of gastrointestinal tract cancer (GIT cancer), but the results were inconsistent. Thus, the investigators conducted a meta-analysis to evaluate the associations between serum carotenoids and risk of GIT cancer.

Study Type

OBSERVATIONAL

Enrollment

40,641

Conditions

Gastrointestinal Tract Cancer

Interventions

serum carotenoidsOTHER

In each study, the serum concentrations of carotenoids were detected by high performance liquid chromatography

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * The study had both case and control groups * Serum carotenoids levels, relative risk (RR) or OR and corresponding 95% CI were reported * Patients in case group were diagnosed with GIT cancer Exclusion Criteria: ·Animal studies

Locations (1)

West China Hospital, Sichuan University

Chengdu, Sichuan, China

Outcomes

Primary Outcomes

Gastrointestinal Tract Cancer Incident Measure

The gastrointestinal tract cancer incident would be recorded during the follow-up years.

Time frame: Through study completion, an average of 5 years.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.